RECRUITING Not applicable ClinicalTrials.gov

Blue-blocking Glasses for Sleep Disorders in Child and Adolescent Psychiatry

Sponsor: Helse Fonna • ClinicalTrials.gov ID: NCT07433491

Registry updated: 2026-09-18

Recruiting for Similar Conditions?

Sponsors are looking for patients like you. See if you qualify for compensated research studies.

Description

Sleep problems and regulation difficulties are frequent in the child and adolescent psychiatry population. Insomnia and delayed sleep-wake phase disorders (DSPWD) are highly prevalent, and risk factors for developing more severe illness courses and chronic disorders. Pharmacological treatments of sleep disorders dominate even for the youngest patients but are unsupported by long-term data on outcome and side effects. The majority of non-pharmacological treatment options are composite and resource demanding. The investigators will examine the effects and feasibility of the isolated intervention of evening/night use of blue-blocking glasses/real darkness as adjunctive treatment for insomnia and delayed sleep phase disorder in inpatient and outpatient settings for children and adolecents.

Interventions

Blue-blocking glasses (BB-glasses) or real darkness from 9 p.m. to desired wake-up time + night mode setting on mobile phone (Device)
Blue-blocking glasses and night mode on mobile phoneBlue-blocking glasses (BB-glasses) or real darkness from 9 p.m. to desired wake-up time + application of dark mode setting on the participant's mobile phone (if not already in use) + registration of brightness on participant's mobile phone screen (%) + treatment as usual
Control (Other)
Application of dark mode setting on the participant's mobile phone (if not already in use) + registration of brightness on particpants's mobile phone screen (%) + Treatment as usual

Eligibility criteria

Inclusion Criteria: * Age 12-18 years, receiving health-care from child and adolescent mental health services at UPA University Hospital of North Norway, Tromsø or BUP Haugesund Hospital, Haugesund * Current Insomnia or DSPD comorbid to one or several pychiatric symptom presentations or diagnoses * Able and willing to provide written informed consent * Participants aged 12-15,9 years also need consent from both parents/carers * Able to comply with protocol * Able to discontinue melatonin or BB-glasses if currently used, with at least 3 days washout period Exclusion Criteria: * Not able to comply with protocol for a required minimum of one night * Blindness or severely reduced translucency of both eyes * Known malformation or damage of optical tract blindness * Use of melatonin all formulas that cannot be paused * High risk for suicide or self-harm * Consent from both partents/carers unlikely (participants age 12-15,9 years)

Conditions

Insomnia Delayed Sleep Phase Disorder Hyperarousal Transdiagnostic Psychopathology Child and Adolescent Psychiatry

Locations

BUP Haugesund — Haugesund, Rogaland, Norway
BUPA Tromsø, The University Hospital of North Norway — Tromsø, Troms, Norway

Partner with Nurenyx

Showcase your study to thousands of motivated patients matching your criteria.

Learn More

Official Source

Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

View Official Record

Accelerate Your Clinical Trial Recruitment